Genetic proxies for PCSK9 inhibition associate with lipoprotein(a): Effects on coronary artery disease and ischemic stroke.
- DOI
- 10.1016/j.atherosclerosis.2022.09.007
- Published
- 2022 Nov
- Container
- Atherosclerosis
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.atherosclerosis.2022.09.007,
title = {Genetic proxies for PCSK9 inhibition associate with lipoprotein(a): Effects on coronary artery disease and ischemic stroke.},
author = {De Marchis GM and Dittrich TD and Malik R and Zietz AV and Kriemler LF and Ference BA and Dichgans M and Georgakis MK},
year = {2022},
journal = {Atherosclerosis},
doi = {10.1016/j.atherosclerosis.2022.09.007},
url = {https://doi.org/10.1016/j.atherosclerosis.2022.09.007}
}RIS
TY - JOUR TI - Genetic proxies for PCSK9 inhibition associate with lipoprotein(a): Effects on coronary artery disease and ischemic stroke. AU - De Marchis GM AU - Dittrich TD AU - Malik R AU - Zietz AV AU - Kriemler LF AU - Ference BA AU - Dichgans M AU - Georgakis MK PY - 2022 JO - Atherosclerosis DO - 10.1016/j.atherosclerosis.2022.09.007 UR - https://doi.org/10.1016/j.atherosclerosis.2022.09.007 ER -
APA
GM, D. M., TD, D., R, M., AV, Z., LF, K., BA, F., M, D., & MK, G. (2022). Genetic proxies for PCSK9 inhibition associate with lipoprotein(a): Effects on coronary artery disease and ischemic stroke.. Atherosclerosis. https://doi.org/10.1016/j.atherosclerosis.2022.09.007
Source records
- pubmed · retrieved 2026-09-27T01:26:31.074Z